LOW DOSE MEDICINE INCREASES BONE MINERAL DENSITY IN WOMEN WITH POSTMENOPAUSAL OSTEOPENIA

被引：0
|
作者：
Nestorova, R. [1 ]
Petranova, T. Z. [2 ]
Todorov, P. [3 ]
机构：
[1] Rheumatol Ctr St Irina, Sofia, Bulgaria
[2] Med Univ, Clin Rheumatol, Sofia, Bulgaria
[3] Univ Hosp Caspela, Clin Rheumatol, Plovdiv, Bulgaria
来源：
OSTEOPOROSIS INTERNATIONAL | 2019年 / 30卷
关键词：
FRACTURES;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P708
引用
收藏
页码：S547 / S547
页数：1
相关论文
共 50 条
  • [1] Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis
    Li, Mei
    Zhang, Zhen-lin
    Liao, Er-yuan
    Chen, De-cai
    Liu, Jian
    Tao, Tian-zun
    Wu, Wen
    Xia, Wei-bo
    Lu, Yu-juan
    Sheng, Zhi-feng
    Lu, Chun-yan
    Meng, Guo-ling
    Xu, Liang
    Zhang, Wei-jie
    Hu, Ying-ying
    Xu, Ling
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2013, 20 (01): : 72 - 78
  • [2] Risedronate increases bone mineral density and is well-tolerated in postmenopausal women with low bone mineral density.
    Ribot, C
    Smith, R
    Fogelman, I
    Bettica, P
    Pack, S
    Ethgen, D
    Reginster, JY
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S136 - S136
  • [3] Sarcopenia in premenopausal and postmenopausal women with osteopenia, osteoporosis and normal bone mineral density
    Walsh, MC
    Hunter, GR
    Livingstone, MB
    [J]. OSTEOPOROSIS INTERNATIONAL, 2006, 17 (01) : 61 - 67
  • [4] Sarcopenia in premenopausal and postmenopausal women with osteopenia, osteoporosis and normal bone mineral density
    Marianne C. Walsh
    Gary R. Hunter
    Margaret Barbara Livingstone
    [J]. Osteoporosis International, 2006, 17 : 61 - 67
  • [5] Simvastatin increases bone mineral density in hypercholesterolemic postmenopausal women
    Lupattelli, G
    Scarponi, AM
    Vaudo, G
    Siepi, D
    Roscini, AR
    Gemelli, F
    Pirro, M
    Latini, RA
    Sinzinger, H
    Marchesi, S
    Mannarino, E
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2004, 53 (06): : 744 - 748
  • [6] Denosumab in postmenopausal women with low bone mineral density
    McClung, MR
    Lewiecki, EM
    Cohen, SB
    Bolognese, MA
    Woodson, GC
    Moffett, AH
    Peacock, M
    Miller, PD
    Lederman, SN
    Chesnut, CH
    Lain, D
    Kivitz, AJ
    Holloway, DL
    Zhang, C
    Peterson, MC
    Bekker, PJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (08): : 821 - 831
  • [7] Romosozumab in Postmenopausal Women with Low Bone Mineral Density
    McClung, Michael R.
    Grauer, Andreas
    Boonen, Steven
    Bolognese, Michael A.
    Brown, Jacques P.
    Diez-Perez, Adolfo
    Langdahl, Bente L.
    Reginster, Jean-Yves
    Zanchetta, Jose R.
    Wasserman, Scott M.
    Katz, Leonid
    Maddox, Judy
    Yang, Yu-Ching
    Libanati, Cesar
    Bone, Henry G.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (05): : 412 - 420
  • [8] Denosumab in postmenopausal women with low bone mineral density
    Schwartzman, Julie
    Yazici, Yusuf
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (22): : 2390 - 2390
  • [9] Romosozumab in postmenopausal women with low bone mineral density
    Tornero Marin, C.
    [J]. REVISTA CLINICA ESPANOLA, 2014, 214 (06): : 345 - 345
  • [10] Denosumab in postmenopausal women with low bone mineral density
    Charles L. Loprinzi
    [J]. Current Oncology Reports, 2006, 8 (4) : 267 - 268
12345